OralDNA Labs launches PCR test for novel coronavirus

By LabPulse.com staff writers

April 15, 2020 -- Dental testing specialist OralDNA Labs has rolled out a polymerase chain reaction (PCR) assay for SARS-CoV-2 from its OraRisk line of salivary diagnostics.

The Eden Prairie, MN-based company plans to apply for emergency use authorization (EUA) with the U.S. Food and Drug Administration (FDA) within 15 days, as required by FDA guidance. The OraRisk COVID-19 PCR test is based on the patented CoPrimer technology of Co-Diagnostics.

RNA extraction for all specimen types is performed using the PerkinElmer Chemagic MSM I automated specimen processing system, with analysis performed on the Roche LightCycler 480 II real-time PCR system.

CAP lends a hand in COVID-19 testing
The College of American Pathologists (CAP) has released a proficiency testing program to help lab professionals evaluate their tests for the novel coronavirus...
OraSure wins BARDA contract for at-home coronavirus test
OraSure Technologies has received a $710,310 contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to develop a pan-SARS-coronavirus...
FDA gives states, vendors more power in coronavirus fight
In a move it called an "unprecedented policy," the U.S. Food and Drug Administration (FDA) on March 16 once again relaxed its regulations on diagnostics...

Copyright © 2020 LabPulse.com

Last Updated np 4/15/2020 10:31:27 AM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current